Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference

Friday, September 14, 2007 General News J E 4
ROCKVILLE, Md., Sept. 14 Human Genome Sciences,Inc. (Nasdaq: HGSI) announced today that its presentation at the Merrill LynchGlobal Pharmaceutical, Biotech & Medtech Conference in London will be webcastand may be accessed at

(Logo: )

A member of Human Genome Sciences' senior management team will present anoverview of the company on Tuesday, September 18, 2007 at 2:20 pm London Time,or 9:20 am Eastern Time.

Investors interested in listening to the live webcast should log on beforethe start time in order to download any software required. The archive of thewebcast will be available for several days after the live event.

The mission of HGS is to apply great science and great medicine to bringinnovative drugs to patients with unmet medical needs.

HGS and Human Genome Sciences are registered trademarks of Human GenomeSciences, Inc. For additional information on Human Genome Sciences, Inc.,visit the company's web site at

SOURCE Human Genome Sciences, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Hooper Holmes Launches Health & Wellness Division ...
Roche Real-Time HIV Test is Faster and Less Labor-...